EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -73.505 | -117.704 | -59.691 | -75.153 | -55.127 | -32.903 | -46.089 | -26.439 |
Return on Equity (%) | -108.046 | -424.977 | -181.346 | -247.125 | -337.866 | -57.576 | -72.844 | -39.039 |
Return on Invested Capital (%) | -105.969 | -124.55 | -55.581 | -82.169 | -62.284 | -38.098 | -44.398 | -38.37 |
Operating Margin (%) | -245.192 | -1771.395 | -1471.243 | -248.549 | -110.744 | -143.261 | -239.264 | -150.952 |
Net Profit Margin (%) | -245.192 | -1795.711 | -1527.322 | -278.876 | -131.818 | -158.145 | -246.966 | -153.842 |
Book Value Per Share | 0.021 | -0.031 | 0.011 | -0.029 | -0.011 | 0.272 | 0.161 | 0.443 |
Earnings Per Share | -0.031 | -0.083 | -0.068 | -0.084 | -0.078 | -0.098 | -0.17 | -0.118 |
Cash Per Share | 0.028 | 0.061 | 0.068 | 0.033 | 0.077 | 0.3 | 0.159 | 0.468 |
Working Capital Per Share | 0.021 | 0.028 | 0.04 | 0.045 | 0.083 | 0.36 | 0.23 | 0.468 |
Operating Profit Per Share | 0.012 | 0.005 | 0.004 | 0.026 | 0.049 | 0.049 | 0.056 | 0.07 |
EBIT Per Share | -0.031 | -0.083 | -0.068 | -0.084 | -0.078 | -0.098 | -0.17 | -0.118 |
EBITDA Per Share | -0.031 | -0.083 | -0.068 | -0.084 | -0.078 | -0.098 | -0.17 | -0.118 |
Free Cash Flow Per Share | -0.032 | -0.085 | -0.069 | -0.088 | -0.082 | -0.103 | -0.171 | -0.113 |
Year End December 30 2023 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 39.36M | 74.51M | 95.37M | 109.42M | 18.14M | N/A | N/A | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 34.07M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -264.897 | N/A | N/A | N/A | -250.633 | N/A |
Net Profit Margin (%) | N/A | N/A | -275.465 | N/A | N/A | N/A | -250.633 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 610.85M |
Price to Earnings Ratio | -8.63 |
Price to Sales Ratio | 13.27 |
Price to Cash Ratio | 2.17 |
Price to Book Ratio | 2.29 |
Dividend Yield | - |
Shares Outstanding | 68.25M |
Average Volume (1 week) | 1.54M |
Average Volume (1 Month) | 1.37M |
52 Week Change | 49.17% |
52 Week High | 30.99 |
52 Week Low | 5.865 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.